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Table S1.a. Demographic and baseline characteristics of included and excluded women 
 
1Women excluded from the analysis were those with invalid/incorrect menstruation responses, and those 
without follow-up data 
2Students t-test for continuous variables and chi-squared test for categorical variables 
*Values were log-transformed before performing statistical test (summary expressed as median and 
interquartile range)  







Demographic and lifestyle factors 
Age, mean (SD) 52.7 (10.5) 53.9 (11.1) 0.001 














Physical activity (PAFQ, min/day) 
• None 
• 1 per week 
• 2 per week 














Drinker (%) 1658 (64.8) 527 (53.4) <0.001 
• Alcohol consumption 
(units/week) 
3.9 (5.4) 3.6 (5.9) 0.107 
Hypertension (%) 705 (27.6) 362 (36.7) <0.001 
• Use of antihypertensive 361 (14.1) 193 (19.6) <0.001 
Smoking 
• Current smoker (%) 
• Former smoker (%) 











Diabetes 79 (3.1) 63 (6.4) <0.001 
• Use of antidiabetic meds 
(%) 
50 (1.9) 42 (4.3) <0.001 
Use of Statins (Lipid lowering drugs) 
(%) 
181 (7.1) 77 (8.8) 0.078 
Use of Hormone replacement therapy 
(%) 
848 (33.2) 346 (35.1) 0.273 
Intermediate cardiovascular risk 
Body mass index (kg/m2) mean (SD) 24.9 (4.7) 25.6 (5.1) 0.0003 
Blood pressure mean (SD)    
• Systolic blood pressure 
(mmHg) 
123.6 (17.6) 126.6 (19.4) 0.001 
• Diastolic blood pressure 
(mmHg) 
77.1 (10.5) 78.5 (10.9) 0.001 
Lipid profile, mean (SD)    
• Total cholesterol 5.57 (0.99) 5.67 (1.10) 0.0076 
• High-density lipoprotein 1.81 (0.42) 1.78 (0.43) 0.0654 
• Triglycerides*  1.0 (0.6) 1.0 (0.7) <0.001 
Glucose metabolism, mean (SD)    
• Fasting glucose 5.29 (0.92) 5.44 (1.2) <0.001 
• Insulin* 6.17 (1.7) 6.61 (5.09) 0.0075 
Inflammatory markers, mean (SD)    
• High sensitivity C reactive 
protein* 
1.3 (2.2) 1.4 (2.8) 0.0016 
• Leptin (score)* 1.17 (1.25) 1.23 (1.3) 0.0725 
• Adiponectin (score)* 1.14 (0.91) 1.08 (0.95) 0.1566 
• Tumor necrosis alpha* 2.68 (2.65) 2.93 (2.78) 0.0713 
• Interleukin 6* 1.18 (2.36) 1.21 (2.42) 0.9828 
• Interleukin 1B* 0.46 (1.95) 0.43 (1.86) 0.8248 
Table S1.b. Number of participants for paired testing (longitudinal analyses) 
 PRE TRANS EPOST LPOST 
Body mass index (kg/m2)  704 504 277 1045 
Systolic blood pressure (mmHg) 704 505 279 1057 
Diastolic blood pressure (mmHg) 704 505 279 1057 
Total cholesterol (mmol/L) 704 505 279 1059 
High density lipoprotein (mmol/L) 704 505 279 1059 
Triglycerides (mmol/L)3 704 505 279 1059 
Fasting glucose (mmol/L) 704 505 279 1059 
Insulin (microIU/mL)3 527 387 226 901 
High sensitivity c-reactive protein3 690 495 278 1050 
Leptin (ng/mL)3, 4 552 379 228 888 
Adiponectin (ng/mL)3,4 573 396 243 935 
Tumor necrosis factor alpha (pg/mL)3 612 419 251 947 
Interleukin 6 (pg/mL)3 521 364 220 858 
Interleukin 1b (pg/mL) 3 353 238 137 464 
Abbreviations: PRE, premenopausal; TRANS, menopause transition; EPOST, early postmenopausal; LPOST, late 
menopausal  














Demographic and Lifestyle factors 
Drinker (%) 568 (80.34) 401 (79.09) 224 (80.00) 799 (75.09) 0.038 
Smoking 
• Current smoker (%) 
• Former smoker (%) 


















Hypertension (%) 63 (8.91) 78 (15.38) 64 (22.86) 420 (39.47) <0.001 
• Use of antihypertensive 30 (4.26) 31 (6.13) 40 (14.34) 311 (29.37) <0.001 
Diabetes 10 (1.42) 19 (3.75) 22 (7.89) 106 (10.00) <0.001 
• Use of antidiabetic meds (%) 3 (0.42) 7 (1.38) 13 (4.64) 56 (5.26) <0.001 
Cardiovascular disease (%) 15 (2.09) 13 (2.56) 18 (6.4) 123 (11.56) <0.001 
Use of Statins (Lipid lowering drugs) (%) 15 (2.12) 33 (6.51) 52 (18.57) 284 (26.69) <0.001 
Cardiovascular risk factors  
Body mass index (kg/m2) mean (SD) 24.75 (4.73) 24.97 (4.71) 25.73 (5.01) 26.34 (5.09) <0.001 
Systolic blood pressure (mmHg) 112.9 (13.6) 117.0 (14.9) 122.1 (18.1) 130.7 (18.8) <0.001 
Diastolic blood pressure (mmHg) 74.2 (10.4) 76.1 (10.2) 76.9 (11.0) 77.7 (10.8) <0.001 
Total cholesterol (mmol/L) 5.39 (0.89) 5.85 (0.98) 6.00 (1.01) 5.97 (1.04) <0.001 
High density lipoprotein (mmol/L) 1.77 (0.41) 1.84 (0.48) 1.81 (0.45) 1.82 (0.46) 0.028 
Triglycerides (mmol/L)3 0.9 (0.5) 1.0 (0.6) 1.0 (0.7) 1.1 (0.6) <0.001 
Fasting glucose (mmol/L) 5.37 (0.77) 5.55 (0.67) 5.73 (1.01) 5.86 (0.98) <0.001 
Insulin (microIU/mL)3  5.5 (4.0) 5.4 (4.3) 6.2 (4.8) 7.1 (5.7) <0.001 
High sensitivity c-reactive protein (pg/mL)3  1.1 (2.2) 1.1 (1.7) 1.35 (1.9) 1.7 (2.7) <0.001 
Leptin (ng/mL)3, 4  0.56 (0.95) 0.60 (0.91) 0.68 (0.88) 0.81 (1.12) <0.001 
Adiponectin (ng/mL) 3,4  0.89 (0.69) 0.91 (0.80) 1.06 (0.99) 1.13 (0.94) <0.001 
Tumor necrosis factor alpha (pg/mL)3  4.02 (4.68) 4.39 (5.62) 4.28 (5.09) 5.05 (5.69) <0.001 
Interleukin 6 (pg/mL) 3  2.20 (6.65) 2.21 (6.14) 2.05 (6.13) 2.47 (5.81) 0.677 
Interleukin 1b (pg/mL) 3  0.62 (2.29) 0.48 (1.80) 0.42 (2.17) 0.39 (1.72) 0.902 
Framingham risk score5 3.17 (2.63) 5.37 (3.76) 8.35 (7.18) 14.23 (9.41) <0.001 
1ANOVA for continuous variables and chi-square test for categorical variables 
2Physical activity was obtained by self-report of doing physical activity for more than 20 mins/day per week 
3Crude values. Transformation of values done in logarithmic scale prior to testing for statistical significance. Summary values expressed as median (interquartile range) 
4Converted to standardized scores 
5 Framingham Risk score computed only for women without a history of cardiovascular disease (PRE 706, TRANS 498, EPOST 266, LPOST 975) 
  
Table S2a. Multivariate regression analysis of cardiovascular risk of women at baseline (cross-sectional analysis)1 
 Pre Transition p Early  p Late  p P value1 
Body mass index         
• Model 1 (Beta, 95%CI) Ref 0.364 (-0.163, 0.890) 0.176 1.425 (0.787, 2.064)* 0.000 2.009 (1.571, 2.448)* 0.000 0.696 (0.555, 0.837)* 
• Model 2 (Beta, 95%CI) Ref 0.278 (-0.300,  0.856) 0.346 1.260 (0.474, 2.047)* 0.002 1.736 (0.857, 2.615)* 0.000 0.606 (0.316, 0.895)* 
• Model 3 (Beta, 95%CI) Ref 0.457 (-0.081, 0.996) 0.096 1.467 (0.722, 2.213)* 0.000 1.993 (1.142, 2.844)*   0.000 0.672 (0.389, 0.954)* 
• Model 4 (Beta, 95%CI) Ref -  -  -   
Systolic blood pressure         
• Model 1 (Beta, 95%CI) Ref 4.074 (2.312, 5.836)* 0.000 7.522 (5.379 - 9.666)* 0.000 14.64 (13.13, 16.15)* 0.000 4.889 (4.403, 5.376)* 
• Model 2 (Beta, 95%CI) Ref -1.138 (-3.083, 0.807) 0.251 -1.683 (-4.329, 0.963) 0.212 -0.419 (-3.379, 2.541) 0.781   -0.102 (-1.047, 0.841) 
• Model 3 (Beta, 95%CI) Ref -0.429 (-2.314, 1.455) 0.655 -1.061 (-3.667, 1.545) 0.425 0.385 (-2.594, 3.364) 0.800 0.074 (-0.910, 1.060) 
• Model 4 (Beta, 95%CI) Ref -0.615 (-2.489, 1.257) 0.519 -1.663 (-4.259, 0.932) 0.209 -0.416 (-3.387, 2.554) 0.783 -0.198 (-1.181, 0.783) 
Diastolic blood pressure         
• Model 1 (Beta, 95%CI) Ref 1.762 (0.599, 2.925)* 0.003 3.196 (1.781, 4.611)* 0.000 2.733 (1.738 , 3.728)* 0.000 0.876 (0.555, 1.198)* 
• Model 2 (Beta, 95%CI) Ref 1.999 (0.721, 3.277)* 0.002 3.648 (1.911, 5.384)* 0.000 3.481 (1.539, 5.424)* 0.000 1.177 (0.537, 1.818)* 
• Model 3 (Beta, 95%CI) Ref 2.191 (0.909, 3.473)* 0.001 4.144 (2.371, 5.916)*   0.000 4.231 (2.205, 6.257)* 0.000 1.448 (0.777, 2.119)* 
• Model 4 (Beta, 95%CI) Ref 1.950 (0.700, 3.200)* 0.002 3.366 (1.634, 5.098)* 0.000 3.195 (1.213, 5.177)* 0.002 1.098 (0.442, 1.754)* 
Total cholesterol         
• Model 1 (Beta, 95%CI) Ref 0.276 (0.171, 0.381)* 0.000 0.784 (0.656, 0.911)* 0.000 0.936 (0.847, 1.026)* 0.000 0.318 (0.289, 0.347)* 
• Model 2 (Beta, 95%CI) Ref 0.106 (-0.007, 0.220) 0.066 0.458 (0.303, 0.614)* 0.000 0.399 (0.226, 0.573)* 0.000 0.146 (0.088, 0.203)* 
• Model 3 (Beta, 95%CI) Ref 0.098 (-0.017, 0.213) 0.097 0.472 (0.312, 0.632)* 0.000 0.424 (0.241, 0.606)* 0.000  0.154 (0.093, 0.214)* 
• Model 4 (Beta, 95%CI) Ref 0.087 (-0.027, 0.202) 0.136 0.440 (0.280, 0.599)* 0.000 0.380 (0.197, 0.562)* 0.000   0.139 (0.079, 0.200)* 
High-density lipoprotein         
• Model 1 (Beta, 95%CI) Ref 0.056 (0.008, 0.104) 0.022 0.074 (0.015, 0.132) 0.014 0.089 (0.048, 0.130) 0.000 0.028 (0.014 - 0.041)* 
• Model 2 (Beta, 95%CI) Ref 0.027 (-0.024, 0.080) 0.298 0.019 (-0.052, 0.091) 0.594 -0.0004 (-0.080, 0.079) 0.991 -0.0009 (-0.027, 0.025) 
• Model 3 (Beta, 95%CI) Ref 0.035 (-0.015, 0.087) 0.172 0.027 (-0.043, 0.098) 0.440 0.006 (-0.074, 0.087) 0.868 0.001 (-0.024, 0.028) 
• Model 4 (Beta, 95%CI) Ref 0.049 (0.001, 0.098)* 0.045 0.071 (0.004, 0.139)* 0.037 0.066 (-0.010, 0.143) 0.092  0.021 (-0.004, 0.046) 
Triglycerides (log)         
• Model 1 (Beta, 95%CI) Ref 0.077 (0.027, 0.128)* 0.002 0.138 (0.077, 0.199)* 0.000 0.243 (0.200, 0.286)* 0.000 0.081 (0.067, 0.094)* 
• Model 2 (Beta, 95%CI) Ref 0.035 (-0.019, 0.090) 0.200 0.058 (-0.016, 0.133) 0.124 0.110 (0.027, 0.194)* 0.009 0.036 (0.008, 0.063)* 
• Model 3 (Beta, 95%CI) Ref 0.029 (-0.024, 0.083) 0.285 0.055 (-0.019, 0.130) 0.150 0.120 (0.035, 0.206)* 0.006 0.038 (0.010, 0.067)* 
• Model 4 (Beta, 95%CI) Ref 0.014 (-0.036, .0066) 0.580 0.008 (-0.063, 0.079) 0.822 0.057 (-0.024, 0.138) 0.170 0.017 (-0.009, 0.044) 
Fasting blood glucose         
• Model 1 (Beta, 95%CI) Ref 0.082 (-0.011, 0.177) 0.085 0.184 ( 0.070, 0.299)* 0.002 0.301 (0.223, 0.380)* 0.000 0.101 (0.076 - 0.127)* 
• Model 2 (Beta, 95%CI) Ref 0.073 (-0.030, 0.176) 0.166 0.166 (0.025, 0.306)* 0.021 0.270 (0.113, 0.428)* 0.001 0.090 (0.038, 0.142)* 
• Model 3 (Beta, 95%CI) Ref 0.105 (0.016, 0.195)* 0.020 0.194 (0.070, 0.317)* 0.002 0.282 (0.141, 0.423)* 0.000 0.093 (0.046, 0.139)* 
• Model 4 (Beta, 95%CI) Ref 0.089 (0.002, 0.176)* 0.045 0.143 (0.022, 0.264)* 0.020 0.213 (0.075, 0.351)* 0.003 0.070 (0.024, 0.115)* 
Serum insulin (log)         
• Model 1 (Beta, 95%CI) Ref -0.024 (-0.092, 0.044) 0.494 0.020 (-0.061, 0.102)* 0.624 0.119 (0.063, 0.176)* 0.000 0.044 (0.026, 0.062)* 
• Model 2 (Beta, 95%CI) Ref -0.013 (-0.088, 0.062) 0.728   0.040 (-0.059, 0.140) 0.427 0.153 (0.041, 0.266)* 0.007 0.052 (0.014, 0.089)* 
• Model 3 (Beta, 95%CI) Ref -0.001 (-0.075, 0.073) 0.977 0.045 (-0.055, 0.146) 0.377 0.169 (0.054, 0.285)*  0.004 0.093 (0.046, 0.139)* 
• Model 4 (Beta, 95%CI) Ref -0.030 (-0.099, 0.038) 0.386 -0.026 (-0.119, 0.067) 0.586 0.067 (-0.039, 0.174) 0.217 0.070 ( 0.024, 0.116)* 
High sensitivity C reactive protein 
(log) 
        
• Model 1 (Beta, 95%CI) Ref 0.013 (-0.113,  0.139) 0.839 0.147 (-0.005, 0.300) 0.059 0.440 (0.335, 0.545)* 0.000 0.154 (0.120 - 0.188)* 
• Model 2 (Beta, 95%CI) Ref -0.027 (-0.166, 0.111) 0.698 0.069 (--0.119, 0.257) 0.469 0.311 (0.101, 0.521)* 0.004 0.104 (0.035, 0.174)* 
• Model 3 (Beta, 95%CI) Ref -0.006 (-0.143, 0.130) 0.927 0.025 (-0.163, 0.214) 0.791     0.234 (0.018, 0.450)* 0.033 0.073 (0.002, 0.145)* 
• Model 4 (Beta, 95%CI) Ref -0.057 (-0.182, 0.067) 0.371 -0.125 (-0.298, 0.047) 0.154 0.030 (-0.167, 0.228) 0.761 0.005 (-0.059, 0.071) 
Leptin (log-score)         
• Model 1 (Beta, 95%CI) Ref -0.007 (-0.099, 0.084) 0.870 0.158 (0.049, 0.267)* 0.005 0.242 (0.167, 0.317)* 0.000 0.087 (0.063, 0.111)* 
• Model 2 (Beta, 95%CI) Ref -0.010 (-0.111, 0.090) 0.840 0.153 (0.018 , 0.288)* 0.026 0.233 (0.082, 0.385)* 0.003 0.084 (0.034, 0.134)* 
• Model 3 (Beta, 95%CI) Ref 0.020 (-0.078, 0.118) 0.685 0.181 (0.046, 0.315)* 0.008 0.261 (0.107, 0.415)* 0.001 0.073 (0.002, 0.145)* 
• Model 4 (Beta, 95%CI) Ref -0.019 (-0.097, 0.058) 0.628 0.064 (-0.042, 0.170) 0.240 0.085 (-0.037, 0.208) 0.171 0.030 (-.009, 0.071) 
Adiponectin (log-score)         
• Model 1 (Beta, 95%CI) Ref 0.0001 (-0.075, 0.075) 0.997 0.126 (0.038, 0.215)* 0.005 0.167 (0.106, 0.229)* 0.000 0.060 (0.041, 0.080)* 
• Model 2 (Beta, 95%CI) Ref -0.028 (-0.111, 0.053)   0.491 0.071 (-0.037, 0.181) 0.199   0.075 (-0.047, 0.198) 0.229 0.030 (-0.009, 0.071) 
• Model 3 (Beta, 95%CI) Ref -0.023 (-0.105, 0.058) 0.576 0.090 (0.020, 0.201) 0.111 0.107 (-0.020, 0.235) 0.099 0.040 (-0.001, 0.082) 
• Model 4 (Beta, 95%CI) Ref -0.004 (-0.085, 0.075) 0.910 0.137 (0.028, 0.246)* 0.013 0.173 (0.047, 0.298)*  0.007 0.061 (0.020, 0.103)* 
TNF alpha (log)         
• Model 1 (Beta, 95%CI) Ref 0.023 (-0.083, 0.129) 0.668 0.135 (0.008, 0.261) 0.037 0.178 (0.091, 0.266)* 0.000 0.062 (0.034, 0.090)* 
• Model 2 (Beta, 95%CI) Ref 0.003 (-0.113, 0.119) 0.958 0.096 (-0.059, 0.252) 0.228 0.114 (-0.061, 0.289) 0.204 0.041 (-0.016, 0.099) 
• Model 3 (Beta, 95%CI) Ref 0.0009 (-0.116, 0.118) 0.988 0.066 (-0.094, 0.226) 0.419 0.082 (-0.102, 0.267) 0.382 0.030 (-0.030, 0.091) 
• Model 4 (Beta, 95%CI) Ref -0.007 (-0.124, 0.109) 0.897 0.042 (-0.118, 0.203) 0.605 0.050 (-0.134, 0.235) 0.594 0.019 (-0.041, 0.080) 
Interleukin 6 (log)         
• Model 1 (Beta, 95%CI) Ref 0.0531 (-0.118, 0.224) 0.542 0.128 (-0.076, 0.331) 0.218 0.101 (-0.039, 0.242)   0.158   0.033 (-0.011, 0.078)* 
• Model 2 (Beta, 95%CI) Ref 0.175 (-0.012 -0.362)   0.067 0.361 (0.111, 0.611)* 0.005 0.493 (0.210, 0.775)* 0.001 0.165 (0.072, 0.258)* 
• Model 3 (Beta, 95%CI) Ref 0.175 (-0.013, 0.365) 0.069 0.374 (0.116, 0.631)* 0.004 0.479 (0.182, 0.775)* 0.002 0.165 (0.066, 0.263)* 
• Model 4 (Beta, 95%CI) Ref 0.163 (-0.025, 0.352) 0.090 0.342 (0.084, 0.600)* 0.009   0.436 (0.138, 0.734)* 0.004 0.151 (0.052, 0.249)* 
Interleukin 1b (log)         
• Model 1 (Beta, 95%CI) Ref -0.187 (-0.396, 0.020) 0.077 -0.139 (-0.389. 0.111) 0.276 -0.167 (-0.342, 0.007) 0.060 -0.046 (-0.102, 0.010) 
• Model 2 (Beta, 95%CI) Ref -0.158 (-0.386, 0.070) 0.175 -0.081 (-0.391, 0.227) 0.604 -.071 (-0.423, 0.280) 0.692 -0.017 (-0.133, 0.098) 
• Model 3 (Beta, 95%CI) Ref -0.181 (-0.413, 0.049) 0.124 -0.122 (-0.443, 0.197) 0.451 -0.124 (0.494, 0.245) 0.509 -0.035 (-0.158, 0.086) 
• Model 4 (Beta, 95%CI) Ref -0.169 (-0.401, 0.062) 0.152 -0.097 (-0.418, 0.222) 0.550 -0.087 (-0.459, 0.283) 0.644 -0.023 (-0.146, 0.098) 
Model 1: corrected for medication 
Model 2: corrected for model 1+ age 
Model 3: corrected for model 2 + smoking history, alcohol-use, baseline physical activity, baseline cardiovascular disease, use of hormone replacement therapy 
Model 4: corrected for model 3+ body mass index 
1Beta-coefficients with 95% confidence interval 
2p value for trend using simple linear regression showing trend (*p value >0.05) 
 
  
Table S2b. Sensitivity analysis 1 (Linear regression model using different inclusion criteria for women)1 
Multivariate linear regression on fully corrected models (model 4) using different “inclusion criteria” (1) fully corrected model (n=2588), (2) natural menopause (n=2241), (3) 
non-HRT users (n=1715), (4) women with no comorbidities (n=1213) 
 Pre Transition p Early  
 
p Late  
 
p 
Body mass index        
• Fully corrected model Ref 0.457 (-0.081, 0.996) 0.096 1.467 (0.722, 2.213) 0.000* 1.993 (1.142, 2.844)   0.000* 
• Natural menopause Ref 0.267 (-0.280, 0.815) 0.339 0.893 (0.127, 1.659) 0.022* 0.799 (-0.078, 1.679) 0.075 
• Non-HRT users Ref 0.542 (-0.042, 1.128) 0.069 1.451 (0.537, 2.365) 0.002* 2.361 (1.277, 3.444) 0.000 *  
• No comorbidities Ref 0.228 (-0.369, 0.826) 0.454 0.084 (-0.953, 1.121) 0.874 0.593 (-0.653, 1.839) 0.351 
Systolic blood pressure        
• Fully corrected model Ref -0.615 (-2.489, 1.257) 0.519 -1.663 (-4.259, 0.932) 0.209 -0.416 (-3.387, 2.554) 0.783 
• Natural menopause Ref -0.603 (-2.492, 1.285) 0.531 -1.983 (-4.629, 0.662) 0.142 -1.204 (-4.243, 1.834) 0.437 
• Non-HRT users Ref -0.463 (-2.358, 1.432) 0.632 -2.597 (-5.563, 0.368) 0.086 -0.267 (-3.797, 3.262) 0.882 
• No comorbidities Ref 0.129 (-1.415, 1.673) 0.870 -1.629 (-4.307, 1.049) 0.233 0.850 (-2.369, 4.069) 0.604 
Diastolic blood pressure        
• Fully corrected model Ref 1.950 (0.700, 3.200) 0.002* 3.366 (1.634, 5.098) 0.000* 3.195 (1.213, 5.177) 0.002* 
• Natural menopause Ref 1.891 (0.610, 3.173) 0.004* 2.681 (0.887, 4.476) 0.003* 2.302 (0.241, 4.363) 0.029* 
• Non-HRT users Ref 1.542 (0.205, 2.881) 0.024* 1.322 (-0.771, 3.416) 0.216 1.793 (-0.699, 4.285) 0.158 
• No comorbidities Ref 0.361 (-0.833, 1.556) 0.553 -0.692 (-2.764, 1.379) 0.512   -0.148 (-2.639, 2.342) 0.907 
Total cholesterol        
• Fully corrected model Ref 0.087 (-0.027, 0.202) 0.136 0.440 (0.280, 0.599) 0.000* 0.380 (0.197, 0.562) 0.000*  
• Natural menopause Ref 0.073 (-0.044, 0.191) 0.221 0.365 (0.201, 0.5298) 0.000* 0.287 (0.099, 0.476) 0.003* 
• Non-HRT users Ref 0.054 (-0.066, 0.174) 0.373 0.388 (0.201, 0.576) 0.000* 0.248 (0.024, 0.471) 0.029* 
• No comorbidities Ref -0.011 (-0.145, 0.122) 0.868   0.250 (0.019, 0.481) 0.034* 0.228 (-0.049, 0.506) 0.107 
High density lipoprotein        
• Fully corrected model Ref 0.049 (0.001, 0.098) 0.045* 0.071 (0.004, 0.139) 0.037* 0.066 (-0.010, 0.143) 0.092  
• Natural menopause Ref 0.044 (-0.006, 0.094) 0.082 0.058 (-0.012, 0.128) 0.103 0.047 (-0.033, 0.127) 0.251 
• Non-HRT users Ref 0.044 (-0.005, 0.094) 0.081 0.087 (0.010, 0.165) 0.027* 0.015 (-0.077, 0.108) 0.744 
• No comorbidities Ref 0.027 (-0.030, 0.0835) 0.360 0.044 (-0.055, 0.143) 0.380 0.048 (-0.166, 0.071) 0.431 
Triglycerides (log)        
• Fully corrected model Ref 0.014 (-0.036, .0066) 0.580 0.008 (-0.063, 0.079) 0.822 0.057 (-0.024, 0.138) 0.170 
• Natural menopause Ref 0.015 (-0.038, 0.068) 0.569 -0.008 (-0.082, 0.066) 0.825 0.007 (-0.078, 0.092) 0.865 
• Non-HRT users Ref 0.019 (-0.037, 0.075) 0.507 0.029 (-0.058, 0.117) 0.506 0.125 (0.021, 0.230) 0.018* 
• No comorbidities Ref 0.031 (-0.044, 0.106) 0.418 -0.032 (-0.162, 0.098) 0.632 0.109 (-0.047, 0.2659) 0.172 
Fasting blood glucose        
• Fully corrected model Ref 0.089 (0.002, 0.176) 0.045* 0.143 (0.022, 0.264)* 0.020* 0.213 (0.075, 0.351) 0.003* 
• Natural menopause Ref 0.094 (0.016, 0.172) 0.018* 0.160 (0.051, 0.269) 0.004* 0.184 (0.059, 0.310) 0.004* 
• Non-HRT users Ref 0.075 (-0.016, 0.166) 0.106   0.081 (-0.061, 0.224) 0.264 0.202 (0.032, 0.371) 0.020*  
• No comorbidities Ref 0.058 (-0.012, 0.129) 0.105 -0.017 (-0.139, 0.105) 0.785 0.064 (-0.083, 0.211) 0.392 
Serum insulin (log)        
• Fully corrected model Ref -0.030 (-0.099, 0.038) 0.386 -0.026 (-0.119, 0.067) 0.586 0.067 (-0.039, 0.174) 0.217 
• Natural menopause Ref -0.032 (-0.104, 0.039) 0.372 -0.042 (-0.140, 0.055) 0.394 0.006 (-0.059, 0.169) 0.342   
• Non-HRT users Ref -0.041 (-0.116, 0.033) 0.277 -0.052 (-0.168, 0.064) 0.379 0.104 (-0.033, 0.241) 0.137 
• No comorbidities Ref -0.244 (-1.030, 0.543) 0.543 -0.237 (-1.616, 1.142) 0.736 1.162 (-0.498, 2.823) 0.170 
High sensitive C reactive protein        
• Fully corrected model Ref -0.057 (-0.182, 0.067) 0.371 -0.125 (-0.298, 0.047) 0.154 0.030 (-0.167, 0.228) 0.761 
• Natural menopause Ref -0.031 (-0.161, 0.099) 0.636 -0.023 (-0.205, 0.159) 0.806 0.182 (-0.027, 0.391) 0.088 
• Non-HRT users Ref -0.031 (-0.123, 0.060) 0.503 -0.023 (-0.151, 0.106) 0.728 0.181 (0.034, 0.329)   0.016* 
• No comorbidities Ref 0.038 (-0.123, 0.120) 0.642 -0.059 (-0.339, 0.220) 0.675 0.295 (-0.042, 0.631) 0.086   
Leptin (log-score)        
• Fully corrected model Ref -0.019 (-0.097, 0.058) 0.628 0.064 (-0.042, 0.170) 0.240 0.085 (-0.037, 0.208) 0.171 
• Natural menopause Ref 0.0005 (-0.078, 0.079) 0.989 0.090 (0.019, 0.199) 0.106 0.104 (-0.022, 0.232) 0.105 
• Non-HRT users Ref 0.007 (-0.076, 0.091) 0.860 0.102 (-0.027, 0.230) 0.121 0.184 (0.030, 0.338) 0.019* 
• No comorbidities Ref 0.015 (-0.081, 0.112) 0.755 0.131 (-0.035, 0.296) 0.121 0.169 (-0.033, 0.371) 0.100 
Adiponectin (log-score)        
• Fully corrected model Ref -0.004 (-0.085, 0.075 0.910 0.137 (0.028, 0.246) 0.013* 0.173 (0.047, 0.298)  0.007* 
• Natural menopause Ref -0.001 (-0.083, 0.081) 0.979 0.131 (0.019, 0.244) 0.022* 0.173 (0.042, 0.304) 0.010* 
• Non-HRT users Ref 0.015 (-0.070, 0.099) 0.735 0.223 (0.094, 0.353) 0.001* 0.213 (0.057, 0.369) 0.007* 
• No comorbidities Ref 0.015 (-0.081, 0.111) 0.762 0.230 (0.068, 0.392) 0.006* 0.234 (0.034, 0.434) 0.022* 
Interleukin 6        
• Fully corrected model Ref 0.163 (-0.025, 0.352) 0.090 0.342 (0.084, 0.600) 0.009* 0.436 (0.138, 0.734) 0.004* 
• Natural menopause Ref 0.153 (-0.046, 0.351) 0.132 0.355 (0.080, 0.629) 0.011* 0.499 (0.181, 0.818) 0.002*   
• Non-HRT users Ref 0.216 (0.008, 0.424) 0.042* 0.410 (0.093, 0.729) 0.011* 0.532 (0.146, 0.919) 0.007* 
• No comorbidities Ref   0.151 (-0.098, 0.400) 0.235 0.469 (0.045, 0.892) 0.030* 0.568 (0.0412, 1.095)   0.035* 
Tumor necrosis factor alpha        
• Fully corrected model Ref -0.007 (-0.124, 0.109) 0.897 0.042 (-0.118, 0.203) 0.605 0.050 (-0.134, 0.235) 0.594 
• Natural menopause Ref -0.032 (-0.155, 0.091) 0.609 0.081 (-0.090, 0.251) 0.353   0.054 (-0.143, 0.253) 0.586 
• Non-HRT users Ref -0.004 (-0.130, 0.123) 0.954 0.146 (-0.050, 0.343) 0.145 0.067 (-0.169, 0.303) 0.578 
• No comorbidities Ref -0.032 (-0.184, 0.120) 0.678 0.158 (-0.104, 0.419) 0.237 0.102 (-0.219, 0.423) 0.534 
Interleukin 1b (log)        
• Fully corrected model Ref -0.169 (-0.401, 0.062) 0.152 -0.097 (-0.418, 0.222) 0.550 -0.087 (-0.459, 0.283) 0.644 
• Natural menopause Ref -0.170 (-0.411, 0.071) 0.167 -0.042 (-0.378, 0.292) 0.802   0.042 (-0.351, 0.435)  0.833   
• Non-HRT users Ref -0.110 (-0.363, 0.142) 0.390 0.155 (-0.242, 0.553) 0.443 -0.143 (-0.619, 0.333) 0.556 
• No comorbidities Ref -0.105 (-0.395, 0.185) 0.477 0.144 (-0.364, 0.651) 0.578 -0.021 (-0.632, 0.590) 0.947 
Model 1: corrected for medication 
Model 2: corrected for model 1+ age 
Model 3: corrected for model 2 + smoking history, alcohol-use, baseline physical activity, baseline cardiovascular disease, use of hormone replacement therapy 
Model 4: corrected for model 3+ body mass index (except for BMI as an outcome) 
1Beta-coefficients with 95% confidence interval 
  










Body mass index (kg/m2) 0.9 (0.7, 1.0) 0.8 (0.6, 0.9) 0.4 (0.2, 0.7) 0.5 (0.4, 0.6) <0.0001 
Systolic blood pressure (mmHg) -1.7 (-2.5, -0.8) -1.9 (-3.1, -0.7) -1.3 (-3.1, 0.5) -1.0 (-2.1, 0.03) 0.6850 
Diastolic blood pressure (mmHg) -0.4 (-1.1, 0.2) -0.5 (-1.3, 0.4,) -1.6 (-0.4, -2.7) -1.0 (-1.6, -0.4) 0.2819 
Total cholesterol (mmol/L) 0.3 (0.3, 0.4) 0.5 (0.4, 0.6) 0.2 (0.05, 0.3) 0.03 (0.04, 0.1) <0.0001 
High density lipoprotein (mmol/L) -0.003 (-0.02, 0.02) 0.002 (-0.02, 0.02) -0.01 (-0.05, 0.02) -0.01 (-0.03, 0.01) 0.2282 
Triglycerides (mmol/L)3 0.5 (0.02, 0.09) 0.08 (0.03, 0.1) 0.10 (0.03, 0.16) 0.02 (-0.02, 0.05) 0.0475 
Fasting glucose (mmol/L) 0.3 (0.2, 0.3) 0.4 (0.3, 0.4) 0.4 (0.3, 0.5) 0.4 (0.3, 0.4) 0.0296 
Insulin (microIU/mL)3 -0.6 (-1.1, -0.2) 0.01 (-0.5, 0.5) 1.38 (0.5, 2.3) 0.6 (0.2, 1.0) <0.0001 
High sensitivity c-reactive protein3 0.1 (-0.2, 0.4) -0.1 (-0.4, 0.1) 0.3 (-0.1, 0.6) 0.1 (-0.2, 0.3) 0.5578 
Leptin (ng/mL)3,4 -0.4 (-0.5, -0.4) -0.4 (-0.5, -0.4) -0.6 (-0.6, -0.5) -0.6 (-0.6, -0.5) 0.0242 
Adiponectin (ng/mL)3,4 -0.05, (-0.1, 0.01) -0.01 (-0.08, 0.06) -0.08 (-0.2, 0.04) -0.01 (-0.07, 0.04) 0.8100 
Tumor necrosis factor alpha (pg/mL)3 3.8 (-11.9, 19.5) 4.1 (2.2, 6.0) -1.9 (-11.5, 7.8) 3.1, (1.2, 5.0) 0.9024 
Interleukin 6 (pg/mL)3 9.1 (3.7, 14.5) 10.7 (3.1, 18.6) 11.6 (3.1, 20.1) 9.5 (4.2, 14.7) 0.9639 
Interleukin 1b (pg/mL) 3 -1.0 (-5.5, 3.4) -0.4 (-1.9, 1.1) 2.6 (-1.6, 6.8) 0.5 (-0.3, 1.3) 0.4981 
Framingham Risk score5 -0.9 (-1.0, -0.7) -1.6 (-1.8, -1.3) -2.1 (-2.7, -1.4) -2.2 (-2.6, -1.8) <0.0001 
1 Mean difference of baseline and follow-up and confidence interval (baseline levels minus follow-up levels). Positive values denote decreasing levels, while negative values 
mean increasing levels.  
2Statistical significance computed using ANOVA to compare the mean difference across groups 
3Crude mean change. Transformation of values done in logarithmic scale prior to testing for statistical significance.  
4Converted to standardized scores 
5Framingham Risk score computed only for women without cardiovascular disease (Number of women included in analyses: PRE 668, TRANS 477, EPOST 255, LPOST 900) 
  
 
Table S3b. Linear mixed models analysis1  
Repeated measures linear mixed models analyzed with restricted maximum likelihood analysis of square root corrected for (1) medication, (2) age, (3) other factors, (4) other factors+BMI 
comparing cardiovascular risk factors from baseline and 5 years follow-up (follow-up1 ), reporting beta coefficient, confidence interval, and p-values for random effects 
 Pre Transition p Early  
 
p Late  
 
p 
Body mass index        
• Model 1 (Beta, 95%CI) Ref 4.031 (-2.186, 10.25) 0.204 1.031 (-6.722, 8.784) 0.794 -0.733 (-6.204, 4.739) 0.793 
• Model 2 (Beta, 95%CI) Ref 3.941 (-2.289, 10.17) 0.215 0.900 (-6.873, 8.673) 0.820 -0.862 (-6.361, 4.636) 0.759 
• Model 3 (Beta, 95%CI) Ref 2.926 (-2.764, 8.615) 0.314 1.494 (-5.604, 8.591) 0.680 0.324 (-4.795, 5.443) 0.901 
• Model 4 (Beta, 95%CI) Ref -  -  -  
Systolic blood pressure        
• Model 1 (Beta, 95%CI) Ref 9.579 (-9.368,28.53) 0.322 1.077 (-22.53,24.68) 0.929 19.34 (2.634,36.06)* 0.023 
• Model 2 (Beta, 95%CI) Ref 2.122 (-16.13,20.38) 0.820 -10.25 (-33.01,12.51) 0.377 8.262 (-7.885,24.41) 0.316 
• Model 3 (Beta, 95%CI) Ref -0.292 (-18.44,17.85) 0.975 -11.46 (-34.08,11.16) 0.321 7.707 (-8.647,24.06) 0.356 
• Model 4 (Beta, 95%CI) Ref -1.279 (-19.33,16.78) 0.890 -12.04 (-34.54,10.47) 0.294 7.611 (-8.659,23.88) 0.359 
Diastolic blood pressure        
• Model 1 (Beta, 95%CI) Ref 5.442 (-6.887, 17.77) 0.387 -1.151 (-16.51, 14.21) 0.883 5.262 (-5.611, 16.135) 0.343 
• Model 2 (Beta, 95%CI) Ref 5.725 (-6.624, 18.07) 0.364 -0.723 (-16.12, 14.68) 0.927 5.680 (-5.243, 16.60) 0.308 
• Model 3 (Beta, 95%CI) Ref 3.681 (-8.582, 15.95) 0.557 -1.926 (-17.23, 13.38) 0.805 5.100 (-5.963, 16.16) 0.366 
• Model 4 (Beta, 95%CI) Ref 2.173 (-9.796, 14.14) 0.722 -2.734 (-17.66, 12.19) 0.719 4.892 (-5.895, 15.68) 0.374 
Total cholesterol        
• Model 1 (Beta, 95%CI) Ref 0.761 (-0.356, 1.878) 0.182 1.418 (0.0250, 2.810)* 0.046 1.245 (0.261, 2.229)* 0.013 
• Model 2 (Beta, 95%CI) Ref 0.534 (-0.574, 1.643) 0.345 1.074 (-0.310, 2.457) 0.128 0.903 (-0.0767, 1.883) 0.071 
• Model 3 (Beta, 95%CI) Ref 0.568 (-0.550, 1.686) 0.319 1.125 (-0.270, 2.520) 0.114 0.990 (-0.0162, 1.996) 0.054 
• Model 4 (Beta, 95%CI) Ref 0.537 (-0.579, 1.654) 0.346 1.107 (-0.286, 2.500) 0.119 0.992 (-0.013,1.996) 0.053 
High-density lipoprotein        
• Model 1 (Beta, 95%CI) Ref -0.312 (-0.861, 0.238) 0.267 -0.277 (-0.962, 0.409) 0.429 0.0951 (-0.389, 0.579) 0.700 
• Model 2 (Beta, 95%CI) Ref -0.356 (-0.906, 0.194) 0.205 -0.343 (-1.030, 0.343) 0.327 0.0282 (-0.458, 0.514) 0.910 
• Model 3 (Beta, 95%CI) Ref -0.271 (-0.800, 0.259) 0.316 -0.396 (-1.057, 0.265) 0.240 0.0388 (-0.438, 0.515) 0.873 
• Model 4 (Beta, 95%CI) Ref -0.187 (-0.690, 0.315) 0.465 -0.348 (-0.975, 0.279) 0.277 0.0449 (-0.407, 0.497) 0.846 
Triglycerides         
• Model 1 (Beta, 95%CI) Ref 0.667 (0.131, 1.202)* 0.015 0.244 (-0.423, 0.911) 0.474 0.169 (-0.301, 0.641) 0.480 
• Model 2 (Beta, 95%CI) Ref 0.617 (0.082, 1.153)* 0.024 0.170 (-0.497, 0.839) 0.616 0.095 (-0.377, 0.568) 0.692   
• Model 3 (Beta, 95%CI) Ref 0.520 (-0.00356,1.043) 0.052 0.237 (-0.416,0.890) 0.477 0.0457 (-0.425,0.517) 0.849 
• Model 4 (Beta, 95%CI) Ref 0.441 (-0.0581,0.941) 0.083 0.198 (-0.425,0.821) 0.534 0.0412 (-0.408,0.491) 0.857 
Fasting blood glucose        
• Model 1 (Beta, 95%CI) Ref 0.584 (-0.387, 1.554) 0.239 0.0908 (-1.119, 1.301) 0.883 0.289 (-0.566, 1.144) 0.508 
• Model 2 (Beta, 95%CI) Ref 0.550 (-0.422, 1.522) 0.268 0.0403 (-1.173, 1.253) 0.948 0.239 (-0.619, 1.098) 0.585 
• Model 3 (Beta, 95%CI) Ref 0.355 (-0.397, 1.108) 0.355 0.0607 (-0.878, 0.999) 0.899 0.152 (-0.525, 0.829) 0.659 
• Model 4 (Beta, 95%CI) Ref 0.274 (-0.461, 1.009) 0.465 0.0149 (-0.902, 0.932) 0.975 0.146 (-0.515, 0.807) 0.665 
Serum insulin (log)        
• Model 1 (Beta, 95%CI) Ref -0.105 (-0.807, 0.597) 0.769 -0.264 (-1.131, 0.604) 0.552 -0.234 (-0.836, 0.368) 0.446 
• Model 2 (Beta, 95%CI) Ref -0.118 (-0.820, 0.585) 0.743 -0.284 (-1.154, 0.585) 0.522 -0.254 (-0.859, 0.351) 0.411 
• Model 3 (Beta, 95%CI) Ref -0.240 (-0.902, 0.421) 0.476 -0.201 (-1.020, 0.617) 0.630 -0.118 (-0.698, 0.463) 0.691 
• Model 4 (Beta, 95%CI) Ref -0.338 (-0.928, 0.253) 0.262 -0.206 (-0.935, 0.523) 0.580 -0.0686 (-0.585,0.448) 0.794 
High sensitive C reactive protein 
(log) 
       
• Model 1 (Beta, 95%CI) Ref 0.580 (-0.740, 1.900) 0.389 -0.443 (-2.079, 1.193) 0.596 0.184 (-0.976, 1.345) 0.756 
• Model 2 (Beta, 95%CI) Ref 0.533 (-0.789, 1.855) 0.429 -0.512 (-2.151, 1.128) 0.541 0.116 (-1.049, 1.282) 0.845 
• Model 3 (Beta, 95%CI) Ref 0.327 (-0.969, 1.623) 0.621 -0.634 (-2.242, 0.973) 0.439 -0.0589 (-1.222, 1.104) 0.921 
• Model 4 (Beta, 95%CI) Ref 0.0541 (-1.126, 1.234) 0.928 -0.775 (-2.237, 0.686) 0.298 -0.0709 (-1.129, 0.987) 0.895 
Leptin (log-score)        
• Model 1 (Beta, 95%CI) Ref 0.458 (-0.734, 1.649) 0.452 0.815 (-0.623, 2.254) 0.266   0.155 (-0.878, 1.187) 0.769 
• Model 2 (Beta, 95%CI) Ref 0.445 (-0.748, 1.638) 0.465 0.793 (-0.648, 2.234) 0.281 0.132 (-0.905, 1.169) 0.802 
• Model 3 (Beta, 95%CI) Ref 0.334 (-0.848,1.516) 0.580 0.698 (-0.731,2.121) 0.338 0.255 (-0.792,1.302) 0.646 
• Model 4 (Beta, 95%CI) Ref 0.173 (-0.835,1.181) 0.736 0.716 (-0.493,1.925) 0.246 0.250 (-0.640,1.139) 0.582 
Adiponectin (log-score)        
• Model 1 (Beta, 95%CI) Ref -0.135 (-0.912, 0.641) 0.732 0.303 (-0.645, 1.251) 0.531 0.444 (-0.221, 1.111) 0.191 
• Model 2 (Beta, 95%CI) Ref -0.192 (-0.969, 0.583) 0.626 0.208 (-0.739, 1.157) 0.666 0.347 (-0.321, 1.016) 0.308 
• Model 3 (Beta, 95%CI) Ref -0.153 (-0.923, 0.616) 0.696 -0.0001 (-0.941, 0.940) 1.000 0.315 (-0.361, 0.991) 0.361 
• Model 4 (Beta, 95%CI) Ref -0.103 (-0.858, 0.651) 0.788 -0.003 (-0.925, 0.919) 0.994 0.313 (-0.349, 0.975) 0.355 
Interleukin 6 (log)        
• Model 1 (Beta, 95%CI) Ref 0.298 (-1.523, 2.120) 0.748 -0.0802 (-2.281, 2.121) 0.943 -0.580 (-2.163, 1.004) 0.473 
• Model 2 (Beta, 95%CI) Ref 0.481 (-1.340, 2.301) 0.605 0.174 (-2.027, 2.375) 0.877 -0.314 (-1.902, 1.275) 0.699 
• Model 3 (Beta, 95%CI) Ref 0.0474 (-1.794, 1.889) 0.960 -0.158 (-2.388, 2.071) 0.889 -0.544 (-2.184, 1.096) 0.516 
• Model 4 (Beta, 95%CI) Ref 0.0174 (-1.824, 1.858) 0.985 -0.173 (-2.401, 2.056) 0.879 -0.554 (-2.193, 1.085) 0.508 
Tumor necrosis factor alpha (log)        
• Model 1 (Beta, 95%CI) Ref 0.256 (-0.845, 1.358) 0.648 0.392 (-0.940, 1.724) 0.564 0.318 (-0.637, 1.273) 0.515 
• Model 2 (Beta, 95%CI) Ref 0.205 (-0.898, 1.309) 0.715 0.316 (-1.018, 1.651) 0.642 0.239 (-0.720, 1.199) 0.624 
• Model 3 (Beta, 95%CI) Ref 0.135 (-0.980,1.250) 0.813 0.169 (-1.182,1.519) 0.807 0.241 (-0.750,1.231) 0.634 
• Model 4 (Beta, 95%CI) Ref 0.106 (-1.008,1.219) 0.852 0.157 (-1.191,1.506) 0.819 0.234 (-0.754,1.223) 0.642 
Interleukin 1b (log)        
• Model 1 (Beta, 95%CI) Ref 0.344 (-1.503, 2.190) 0.715 -0.837 (-3.113, 1.439) 0.471 0.0813 (-1.537, 1.699) 0.922 
• Model 2 (Beta, 95%CI) Ref 0.455 (-1.394, 2.303) 0.630   -0.661 (-2.943, 1.620) 0.570 0.239 (-1.386, 1.864) 0.773 
• Model 3 (Beta, 95%CI) Ref 0.0963 (-1.781, 1.974) 0.920 -1.073 (-3.392, 1.245) 0.364 -0.208 (-1.897, 1.481) 0.809 
• Model 4 (Beta, 95%CI) Ref 0.135 (-1.740, 2.010) 0.888 -1.043 (-3.358, 1.272) 0.377 -0.197 (-1.884,1.490) 0.819 
Model 1: corrected for medication 
Model 2: corrected for model 1+ age 
Model 3: corrected for model 2 + smoking history, alcohol-use, baseline physical activity, baseline cardiovascular disease, use of hormone replacement therapy at baseline 
and follow-up 
Model 4: corrected for model 3+ body mass index at baseline and follow-up 




Table S3c. Sensitivity analysis (Linear mixed models analysis using different inclusion criteria for women)1 
Repeated measures linear mixed models analyzed with restricted maximum likelihood analysis of square on fully corrected models (model 4) using different “inclusion 
criteria” (1) fully corrected model (n=2588), (2) natural menopause (n=2241), (3) non-HRT users (n=1715), (4) healthy women without comorbidities (n=1213) 
 Pre Transition p Early  
 
p Late  
 
p 
Body mass index        
• Fully corrected model Ref 2.926 (-2.764, 8.615) 0.314 1.494 (-5.604,8.591) 0.680 0.324 (-4.795,5.443) 0.901 
• Natural menopause Ref 3.153 (-2.547,8.854) 0.278 1.305 (-5.821, 8.432) 0.720 0.014 (-5.422, 5.451) 0.996 
• Non-HRT users Ref 3.882 (-2.050,9.815) 0.200 0.853 (-6.946,8.653) 0.830 1.332 (-5.577,8.241) 0.706 
• Healthy women Ref 3.186 (-2.512, 8.884) 0.273 -0.255 (-9.204, 8.692) 0.955 -10.46 (-25.99, 5.07) 0.187 
Systolic blood pressure        
• Fully corrected model Ref -1.279 (-19.33, 16.78) 0.890 -12.04 (-34.54, 10.47) 0.294 7.611 (-8.659, 23.88) 0.359 
• Natural menopause Ref -1.441 (-19.64, 16.76) 0.877 -11.44 (-34.18, 11.28) 0.324 4.31 (-13.09, 21.73) 0.627 
• Non-HRT users Ref -2.472 (-20.09, 15.14) 0.783 -7.451 (-30.57, 15.67) 0.528 -6.039 (-26.74, 14.66) 0.568 
• Healthy women Ref -5.865 (-20.41, 8.678) 0.429 1.367 (-21.45, 24.19) 0.907 -29.28 (-68.94, 10.37) 0.148 
Diastolic blood pressure        
• Fully corrected model Ref 2.173 (-9.796, 14.14) 0.722 -2.734 (-17.66, 12.19) 0.719 4.892 (-5.895, 15.68) 0.374 
• Natural menopause Ref 1.614 (-10.58, 13.81) 0.795 -4.27 (-19.51, 10.96) 0.582 0.032 (-11.63, 11.70) 0.996 
• Non-HRT users Ref 1.139 (-11.07, 13.358) 0.855 -1.107 (-17.14, 14.93) 0.892 -2.413 (-16.76, 11.93) 0.742 
• Healthy women Ref -2.410 (-13.32, 8.500) 0.665 8.500 (-8.624, 25.62) 0.331 -19.28 (-49.03, 10.46) 0.204 
Total cholesterol        
• Fully corrected model Ref 0.537 (-0.579, 1.654) 0.346 1.107 (-0.286, 2.500) 0.119 0.992 (-0.013,1.996) 0.053 
• Natural menopause Ref 0.413 (-0.708, 1.535) 0.470 1.103 (-0.299, 2.505) 0.123 1.489 (0.419, 2.558) 0.006 
• Non-HRT users Ref 0.445 (-0.683, 1.594) 0.433 1.442 (-0.054, 2.939) 0.059 0.853 (-0.471, 2.179) 0.207 
• Healthy women Ref 0.630 (-0.581, 1.841) 0.308 1.990 (0.089, 3.890) 0.040 0.297 (-3.004, 3.598) 0.860 
High density lipoprotein        
• Fully corrected model Ref -0.187 (-0.690, 0.315) 0.465 -0.348 (-0.975, 0.279) 0.277 0.0449 (-0.407, 0.497) 0.846 
• Natural menopause Ref -0.177 (-0.686, 0.331) 0.494 -0.332 (-0.968, 0.302) 0.305 0.098 (-0.386, 0.584) 0.690 
• Non-HRT users Ref -0.231 (-0.728, 0.266) 0.362 0.009 (-0.644, 0.664) 0.977 0.0164 (-0.562, 0.595) 0.956 
• Healthy women Ref -0.083 (-0.612, 0.447) 0.759 -0.039 (-0.870, 0.792) 0.927 -0.134 (-1.579, 1.309) 0.855 
Triglycerides (log)        
• Fully corrected model Ref 0.441 (-0.0581,0.941) 0.083 0.198 (-0.425,0.821) 0.534 0.0412 (-0.408,0.491) 0.857 
• Natural menopause Ref 0.477 (-0.027, 0.982) 0.063 0.111 (-0.519, 0.742) 0.730 0.016 (-0.465, 0.496) 0.949 
• Non-HRT users Ref 0.513 (-0.004, 1.031) 0.052 0.279 (-0.401, 0.959) 0.421 0.325 (-0.276, 0.928) 0.289 
• Healthy women Ref 0.347 (-0.216, 0.912) 0.227 -0.094 (-0.980, 0.791) 0.834 0.062 (-1.476, 1.601) 0.937 
Fasting blood glucose        
• Fully corrected model Ref 0.274 (-0.461, 1.009) 0.465 0.0149 (-0.902, 0.932) 0.975 0.146 (-0.515, 0.807) 0.665 
• Natural menopause Ref 0.237 (-0.423, 0.897) 0.482 0.130 (-.6951098    .9560296) 0.757 0.393 (-0.235, 1.022) 0.220 
• Non-HRT users Ref 0.308 (-0.455, 1.072) 0.429 -0.251 (-1.255, 0.753) 0.624 -0.194 (-1.082, 0.695) 0.670 
• Healthy women Ref 0.415 (-0.166, 0.997) 0.162 -0.206 (-1.120, 0.707) 0.658 1.027 (-0.560, 2.614) 0.205 
Serum insulin (log)        
• Fully corrected model Ref -0.338 (-0.928, 0.253) 0.262 -0.206 (-0.935, 0.523) 0.580 -0.0686 (-0.585,0.448) 0.794 
• Natural menopause Ref -0.285 (-0.890, 0.318) 0.354 -0.268 (-1.015, 0.478) 0.481 -0.173 (-0.731, 0.385) 0.544 
• Non-HRT users Ref -0.174 (-0.784, 0.437) 0.577 -0.379 (-1.176, 0.418) 0.351 -0.305 (-0.988, 0.378) 0.381 
• Healthy women Ref -0.091 (-0.733, 0.551) 0.781 -0.220 (-1.201, 0.761) 0.660 -0.422 (-2.094, 1.248) 0.620 
High sensitive C reactive protein        
• Fully corrected model Ref 0.0541 (-1.126, 1.234) 0.928 -0.775 (-2.237, 0.686) 0.298 -0.0709 (-1.129, 0.987) 0.895 
• Natural menopause Ref 0.134 (-1.077, 1.347) 0.827 -0.699 (-2.203, 0.804) 0.362 -0.167 (-1.320, 0.984) 0.776 
• Non-HRT users Ref 0.199 (-1.035, 1.435) 0.751 -1.083 (-2.693, 0.526) 0.187 -0.227 (-1.662,1.206) 0.769 
• Healthy women Ref 0.529 (-0.825, 1.884) 0.444 -0.254 (-2.366, 1.858) 0.813 1.736 (-1.906, 5.379) 0.350 
Leptin (log-score)        
• Fully corrected model Ref 0.173 (-0.835,1.181) 0.736 0.716 (-0.493,1.925) 0.246 0.250 (-0.640,1.139) 0.582 
• Natural menopause Ref 0.189 (-0.837, 1.216) 0.718 0.862 (-0.366, 2.091) 0.169 0.196 (-0.761, 1.153) 0.688 
• Non-HRT users Ref 0.241 (-0.791, 1.273) 0.647 0.778 (-0.519, 2.075) 0.240 0.273 (-0.873, 1.419) 0.640 
• Healthy women Ref 0.076 (-1.062, 1.216) 0.895 .276 (-1.494, 2.046) 0.760 -0.614 (-3.542, 2.313) 0.681 
Adiponectin (log-score)        
• Fully corrected model Ref -0.103 (-0.858, 0.651) 0.788 -0.003 (-0.925, 0.919) 0.994 0.313 (-0.349, 0.975) 0.355 
• Natural menopause Ref -0.204 (-0.966, 0.558) 0.600 -0.065 (-0.996, 0.864) 0.890 0.432 (-0.274, 1.140) 0.230 
• Non-HRT users Ref -0.330 (-1.007, 0.440) 0.401 0.403 (-0.588, 1.392) 0.425 0.110 (-0.745, 0.965) 0.801 
• Healthy women Ref -0.301 (-1.106, 0.505) 0.465 0.989 (-0.251, 2.229) 0.118 -0.041 (-2.108, 2.026) 0.969 
Interleukin 6        
• Fully corrected model Ref 0.0174 (-1.824, 1.858) 0.985 -0.173 (-2.401, 2.056) 0.879 -0.554 (-2.193, 1.085) 0.508 
• Natural menopause Ref 0.234 (-1.666, 2.134) 0.810 -0.045 (-2.345, 2.255) 0.969 -0.695 (-2.485, 1.094) 0.446 
• Non-HRT users Ref 0.206 (-1.726, 2.138) 0.834 -0.511 (-2.958, 1.937) 0.683 -1.296 (-3.494, 0.901) 0.248 
• Healthy women Ref 0.905 (-1.241, 3.052) 0.408 0.034 (-3.207, 3.275) 0.984 -1.448 (-7.147, 4.250) 0.618 
Tumor necrosis factor alpha        
• Fully corrected model Ref 0.106 (-1.008,1.219) 0.852 0.157 (-1.191,1.506) 0.819 0.234 (-0.754,1.223) 0.642 
• Natural menopause Ref 0.141 (-1.009, 1.291) 0.810 0.344 (-1.046, 1.735) 0.628 -0.049 (-1.131, 1.031) 0.928 
• Non-HRT users Ref -0.025 (-1.188, 1.137) 0.966 -0.00154 (-1.477, 1.474) 0.998 0.461 (-0.863, 1.785) 0.495 
• Healthy women Ref -0.283 (-1.575, 1.008) 0.667 0.085 (-1.878, 2.047) 0.933 0.621 (-2.788, 4.031) 0.721 
Interleukin 1b (log)        
• Fully corrected model  Ref 0.135 (-1.740, 2.010) 0.888 -1.043 (-3.358, 1.272) 0.377 -0.197 (-1.884,1.490) 0.819 
• Natural menopause Ref 0.354 (-1.575, 2.284) 0.719 -0.963 (-3.341, 1.415) 0.427 -0.709 (-2.557, 1.140) 0.453 
• Non-HRT users Ref 0.529 (-1.412, 2.471) 0.593 -0.502 (-3.008,2.004) 0.695 0.481 (-1.759,2.722) 0.674 
• Healthy women Ref 1.158 (-0.938, 3.254) 0.279 0.531 (-2.663, 3.727) 0.744 0.949 (-4.905, 6.804) 0.751 
Model 1: corrected for medication 
Model 2: corrected for model 1+ age 
Model 3: corrected for model 2 + smoking history, alcohol-use, baseline physical activity, baseline cardiovascular disease, use of hormone replacement therapy at baseline 
and follow up 
Model 4: corrected for model 3+ body mass index at baseline and follow-up 
1Beta-coefficients with 95% confidence interval 
 
